Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Health: Drugs

House of Lords written question – answered on 25th February 2013.

Alert me about debates like this

Photo of Lord Walton of Detchant Lord Walton of Detchant Crossbench

To ask Her Majesty's Government how they propose to assess the effects of the new system of value-based pricing; and what assessment they made of its impact on access to treatment for cancer patients.

Photo of Earl Howe Earl Howe The Parliamentary Under-Secretary of State for Health

The consultation document, A New Value-Based Approach to the Pricing of Branded Medicines set out our proposals for value-based pricing. The consultation ran from 16 December 2010 to 17 March 2011 and the Government's response to the consultation was published on 18 July 2011, A New Value-Based Approach to the Pricing of Branded Medicines: Government Response to Consultation.

The impact assessment accompanying the consultation document set out an evaluation of the effects of our proposals including an assessment of the possible impact on National Health Service patients, including cancer patients. Copies of the consultation document, the Government's response and the impact assessment have already been placed in the Library.

The impact assessment will be updated in due course as the new pricing arrangements for branded medicines, including value-based pricing, are finalised.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.